HR 4275
115th Congress
House
Crime and Law Enforcement
Drug trafficking and controlled substances
Fraud offenses and financial crimes
Government information and archives
Health personnel
Health promotion and preventive care
Prescription drugs
Empowering Pharmacists in the Fight Against Opioid Abuse Act
Introduced: November 7, 2017
Introduced by:
DeSaulnier, Mark
Democratic
· California
See on congress.gov
Everywhere this bill has been
14 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 13, 2018
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 12, 2018
Motion to reconsider laid on the table Agreed to without objection.
Jun 12, 2018
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5066)
Jun 12, 2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5066)
Jun 12, 2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 4275.
Jun 12, 2018
Considered under suspension of the rules. (consideration: CR H5066-5067)
Jun 12, 2018
Mr. Walden moved to suspend the rules and pass the bill, as amended.
May 9, 2018
Ordered to be Reported (Amended) by Voice Vote.
May 9, 2018
Committee Consideration and Mark-up Session Held.
Apr 25, 2018
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Apr 25, 2018
Subcommittee Consideration and Mark-up Session Held.
Nov 10, 2017
Referred to the Subcommittee on Health.
Nov 7, 2017
Referred to the House Committee on Energy and Commerce.
Nov 7, 2017
Introduced in House
Plain-English summary
Empowering Pharmacists in the Fight Against Opioid Abuse Act
(Sec. 2) This bill requires the Department of Health and Human Services (HHS) to develop and disseminate training programs and materials on: (1) the circumstances under which a pharmacist may refuse to fill a controlled substance prescription suspected to be fraudulent, forged, or indicative of abuse or diversion; and (2) federal requirements related to such refusal.
HHS must seek input from relevant stakeholders.
What's happening now
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committees of jurisdiction
3